Oncology Times | February 25, 2012 Vol.34 Issue 4 | NursingCenter

Oncology Times

February 25, 2012 Volume : 34 Issue Number : 4

Oncology Times

About This Publication

NCPD from this Journal

<< Previous Issue

Featured Articles

Buy

Best Lung Cancer Developments of 2011
Thomas E. Stinchcombe MD
Buy

Brivanib Fails in Phase III Colorectal Cancer Trial
Rabiya S. Tuma PHD
Buy

Fractionated Dosing May Put Gemtuzumab Back in Play
Robert H. Carlson
Buy

'Haplo' Transplant Valid Option for Patients without Conventional Donors
Robert H. Carlson
Buy

How Obesity Complicates Cancer Treatment
Cynthia Washam
Buy

International Consortium Unravels Molecular Secrets of Inflammatory Breast Cancer
Charlene Laino
Buy

Meta-analysis Hormone Therapy Safe for High-Risk Prostate Cancer in Men with No Underlying Heart Disease
Mark Fuerst
Buy

Prostate Cancer: Year in Review
Bruce Roth MD
Buy

Regorafenib Prolongs Overall Survival in Advanced Colorectal Cancer Patients
Rabiya S. Tuma PHD

Departments

Free

FDA Approval for Erivedge, First Treatment for Advanced Basal Cell Carcinoma
Free

FDA Approvals for Supplemental NDA for Velcade for Myeloma and Mantle Cell Lymphoma, and Picato Gel for Actinic Keratosis
Free

FDA Approves Inlyta (Axitinib) for Advanced Kidney Cancer
Free

Lymphoma Highlights from ASH: Important News about Hodgkin Lymphoma, and an Unexpected Negative Transplant Study in Diffuse Large B-Cell Lymphoma
Craig Moskowitz MD
Free

Musings of a Cancer Doctor: On Orthobunyaviruses
George W. Sledge MD
Free

OT iPad App!
Free

Podcast iPad Exclusive! Will CMS Cast Its Eye Toward Oncology?
Free

Shop Talk
Free

Voices: John Donne, Illness, and Cancer
Matthew Katz MD
Buy

Second Thoughts from Sekeres: What We Should Demand from Clinical Trials
Mikkael A. Sekeres MD, MS

All Issues

Volume : 46

Volume : 45

Volume : 44

Volume : 43

Volume : 42

Volume : 41

Volume : 40

Volume : 39

Volume : 38

Volume : 37

Volume : 36

Volume : 35

Volume : 34

Volume : 33

Volume : 32

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.09.00